Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases

D Brandariz‐Nuñez… - Journal of Clinical …, 2021 - Wiley Online Library
What is known and objective Acyclovir and valacyclovir are commonly used antivirals with
good general tolerance. Despite their good safety profile, they can cause systemic adverse …

Application of RFID technology in patient tracking and medication traceability in emergency care

M Martínez Pérez, M Cabrero-Canosa… - Journal of medical …, 2012 - Springer
One of the most important factors that directly affects the quality of health care is patient
safety. Minimize the occurrence of adverse events is one of the main challenges for health …

Teleconsultation for the pharmaceutical care of HIV outpatients in receipt of home antiretrovirals delivery: clinical, economic, and patient-perceived quality analysis

L Margusino-Framiñán, P Cid-Silva… - Telemedicine and e …, 2019 - liebertpub.com
Abstract Background/Introduction: Pharmacist teleconsultations, combined with home drug
delivery or mail-order pharmacy (MOP), can help hospital outpatients with difficulties …

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated …

P Cid‐Silva, N Fernández‐Bargiela… - Basic & clinical …, 2019 - Wiley Online Library
Two elvitegravir/cobicistat‐based therapies combined with emtricitabine/tenofovir disoproxil
fumarate (EVG/c/FTC/TDF) or emtricitabine/tenofovir alafenamide fumarate (EVG/c/FTC/TAF) …

Clinical experience with the integrase inhibitors dolutegravir and elvitegravir in HIV‐infected patients: efficacy, safety and tolerance

P Cid‐Silva, JM Llibre… - Basic & clinical …, 2017 - Wiley Online Library
Two integrase inhibitors (INSTI s), dolutegravir (DTG) and elvitegravir/cobicistat (EVG/COBI),
have joined recently the pharmacotherapy arsenal against HIV. This study evaluated the …

[HTML][HTML] Biologic therapy for moderate to severe psoriasis. Real-world follow-up of patients who initiated biologic therapy at least 10 years ago

L Elberdín, RM Fernández-Torres, S Paradela… - Dermatology and …, 2022 - Springer
Introduction The aim of this study was to evaluate response and drug survival of biologic
therapy in patients with moderate to severe plaque-type psoriasis who initiated biologic …

Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study

N Fernández-Bargiela, S Rotea-Salvo… - European Journal of …, 2022 - ejhp.bmj.com
Objectives Despite the high efficacy of antiretroviral treatment, no drug is free from adverse
events (AEs). Efavirenz (EFV) and dolutegravir (DTG) are antiretroviral drugs for which …

[HTML][HTML] Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting

M García-Queiruga, BF Cortizas… - Revista Española de …, 2021 - ncbi.nlm.nih.gov
Materials and methods Retrospective observational study of the number and type of EIP
prepared in the HPS and of the treated patients. Study period: January 2017 …

[HTML][HTML] Implementation of specialized pharmaceutical care hospital outpatient clinics in a hospital pharmacy department

L Margusino-Framiñán, P Cid-Silva… - Farmacia …, 2017 - Elsevier
Objective To describe the organization of patient care into Specialized Pharmaceutical Care
Hospital Outpatient Clinics in a Hospital Pharmacy Department, to evaluate their healthcare …

Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors

P Cid-Silva, L Margusino-Framiñán, V Balboa-Barreiro… - Aids, 2018 - journals.lww.com
Abstract HIV-1 subtype B (54.4%) and subtype F (27.2%) are the most prevalent variants in
patients who started antiretroviral therapy including an integrase inhibitor in the last 2 years …